Analysts at Systematix Institutional Research and Elara Securities upgraded rating on Dr Reddy's Laboratories stock from 'Hold' to 'Buy' and 'Reduce' to 'Accumulate', respectively.
Analysts at Systematix Institutional Research and Elara Securities upgraded rating on Dr Reddy's Laboratories stock from 'Hold' to 'Buy' and 'Reduce' to 'Accumulate', respectively.
<iframe src="https://hindustansphere.com/embed/cluster/bdc06768c59192890a0171c05207ee00e3ee5483" width="100%" height="320" style="border:0;max-width:680px" loading="lazy" title="Dr Reddy's share price spurts 4% post Q2 earnings; analysts upgrade rating"></iframe>
